As of 2024-12-11, the Fair Value of G1 Therapeutics Inc (GTHX) is -4.24 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.15 USD, the upside of G1 Therapeutics Inc is -159.33%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -122.45 | -99.25 | -148.35 | -147.56 | -47.97 | -113.12 |
| YoY growth | -43.57% | 18.95% | -49.47% | 0.53% | 67.49% | -1.21% |
| Market Cap (mil) | 377.23 |
| P/E | |
| Forward P/E |
| EPS | -0.85 |
| Avg earnings growth rate | -1.21% |
| TTM earnings | -44.77 |